@dansfera: The FDA is shifting the game for clinical trial monitoring, and it’s about time. With traditional oversight falling short, the agency is now looking toward technology to bridge the gap. By leveraging new tech tools, the industry can finally scale monitoring efforts, allowing vendors to shoulder more responsibility. It’s a massive pivot toward doing more with less—and a huge win for clinical trial efficiency. #FDA #ClinicalTrials #HealthTech #RegulatoryUpdate #ClinicalResearch